Bull therapy 101-thread for technical analysis with the fundamentals

monsanto…
on a fine base formation…

acrysil at supports…

For the fundamental developments, refer to the acrysil thread…Acrysil - Kitchen sinks - #42 by Capsule91

Disclaimer… invested

BLS international- After coming back on the growth visibility with a new UK contract which is the largest of all the contracts win by the company till date, and the punjab woes kind of soothed after the news that the punjab gov has allocated the receivables due to bls in the yearly budget[200cr ] and of that 30cr has already come in april…
The scrips now looks like one to be accumulated…
Finding the supports for the impending correction…

Disclaimer… invested

Could be accumulation…

But i think this is redistribution rather…
Most likely the floor of this would be around that blue 200day wilder moving average @411
the 200dma slip without volume surge , shows there are no strong hands left in the system as of now…


Note: current level of 450s is the yearly pivot level…
the yearly support is way below in the lower 300s…

For a accumulation i would like to see dramatic volume surge in the preliminary support and selling climax levels, none of which is there yet… hence accumulation now, is very less likely

looking at the weekly chart there is a massive distribution going on, which we see in the form of a head and shoulder pattern with the neck of it as the yearly pivot and the S1 support below, also the fibonacci primary ratio of 0.618 and the secondary derived ratio of 0.786 levels, around the Yearly s1 support, should be watched as other potential support areas…

Disclaimer… not invested

2 Likes

Thanks for sharing your inputs :slight_smile:

1 Like

Another way to look at everest inds chart on longer term monthly time frame.

4 Likes

titan is due a much needed big correction… with bearish divergence in all the oscillators , the breach of the 59 level in the rsi , is ominous …the post berish cross of the macd with the signal is with a intensifying histogram, and with a bearish price macd divergence…

in the daily chart, the 3 point confluence of the moving average would be a short term support, but further correction is more likely, the head of the curve might be in the form of a potential head and shoulder formation?

Control print is being accumulated as well also, we can see head and shoulder pattern on daily chart.

Hitesh bhai,

What is your view on Indigo? The size of opportunity is big & that is what I find the most attractive in this stock. However, this is capital intensive industry and Indigo has high level of borrowing and I am not sure whether it can achieve high level of RoCE consistently for long term. Would like to know your thoughts.

midcaps on suspected wyckoff reaccumulation, with spring formation likely in the wilder moving average supports…

1 Like

Hi,
What is your reading on coal India technical setup looks like?.

Regards,
Sathish

in continuation of the previous bls post…

this is significant head trauma…definite need for ATLS activation…:smile:

Discaimer… invested and looking to average

1 Like

worth digging in the fundamentals here…
the market seems to be factoring something…

The trade seems to be working out well. Bajaj finance is outperforming the index. However I will be trimming my position to 1/3 and c how does the rest of it pans out. Another interesting pattern is emerging out of mindtree. It has consolidated long enough and is on the verge of breakout. Fundamental and results of the stock seem good.
Disc: have positions in both bajaj finance and mindtree from lower levels.

1 Like

another interesting scrip to dig into the fundamentals, i believe wyckoff reaccumulation in phase b[may also have merged with phase c] is going on…

Disclaimer… not invested, bumped in to the chart, will start with fundamental analysis

one of the successful springs…

the technical gets interesting from here…

bottom out seems to be coming up in coming few months…

DCM Shriram - Pullback due to buyback. Had posted earlier around 250 when it was consolidating around 250 (200 WMA). Big volumes today and RSI looking good and MACD crossover could happen as well (confirmation). Money-flow as well shows oversold levels. SOTP valuation showed that it was trading at just Chlor-Alkali business valuation at Rs.250.

BSE - Pulling past the resistance trendline after 4.5 months

Disc: Have a position post big fall in DCM Shriram. Took a position in BSE yesterday looking for a breakout.

1 Like

TTK Healthcare monthly - Long-term charts from 2010 to present. Currently resting on the long-term support trendline. There are some fundamental triggers as well with the recent TTK PDL (Skore condoms) merger. Being in diversified businesses though, its hard to say how the market will value the business. Protective devices make up about 23% of the topline and 28% of the bottomline. Negligible debt, 75% promoter holding and 135 Cr cash on a EV of 1100 Cr should cap the bottom at where the support trendline is.

Disc: Invested recently

2 Likes

The interesting chart of torrent pharma caught my eye…
Wyckoff re-acumulation seems to be underway…
The fundamentals need a serious look…

Some updates-
TRP filed 13 ANDAs in FY18 [us market],currently 46 ANDAs are pending for approval including six from Biopharma.,Overall it has 51 filings pending with US FDA including 5 tentative approvals,plans to file 15-20 ANDAs in the US in FY19 and expects eight to 10 approvals. Launched Hydrocodonsuppository from Biopharma portfolio in 4QFY18, To launch 8-9 products in FY19, Spent Rs 4.6bn in R&D in FY18, Unichem domestic portfolio has started growing post acquisition, Brazil was flat due to higher base and disturbances, single digit [5-6%]growth in Brazil in FY19 expected, To see strong growth in Germany in FY19,launched 17 products in Germany in FY18 and plans to launch 16 more in FY19, Expect 27% effective tax rate in FY19, Capex guidance at Rs 2bn for FY19 (maintenance capex mainly, believes most of the fresh capex has been done in FY18).
The chronic: acute ratio for the domestic formulations is 3:1…
Management expects significant synergies from the acquisition and have guided for the Unichem portfolio to exceed market growth rate in the near to medium term.

Disclaimer…definitely interested, learning the fundamental story here , no positions as yet

2 Likes